Daclizumab Subcutaneous and Hydrochlorothiazide and bisoprolol
Determining the interaction of Daclizumab Subcutaneous and Hydrochlorothiazide and bisoprolol and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: bisoprolol / hydrochlorothiazide
Brand name: Ziac
Synonyms: Bisoprolol and Hydrochlorothiazide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Hydrochlorothiazide and candesartan
- Daclizumab Subcutaneous-Hydrochlorothiazide and captopril
- Daclizumab Subcutaneous-Hydrochlorothiazide and enalapril
- Daclizumab Subcutaneous-Hydrochlorothiazide and fosinopril
- Daclizumab Subcutaneous-Hydrochlorothiazide and irbesartan
- Daclizumab Subcutaneous-Hydrochlorothiazide and lisinopril
- Hydrochlorothiazide and bisoprolol-Dacogen
- Hydrochlorothiazide and bisoprolol-Dacomitinib
- Hydrochlorothiazide and bisoprolol-Dactinomycin
- Hydrochlorothiazide and bisoprolol-Dactinomycin Injection
- Hydrochlorothiazide and bisoprolol-Dactinomycin Intravenous
- Hydrochlorothiazide and bisoprolol-Daklinza